# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000059478-25-000109
Filing Date
2025-03-21
Accepted
2025-03-21 16:14:03
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | llydefa14a2025_additionalm.htm | DEFA14A | 12894
2 |  | finalnotices_pagex1.jpg | GRAPHIC | 499645
3 |  | finalnotices_pagex2.jpg | GRAPHIC | 382101
4 |  | finalnotices_pagex3.jpg | GRAPHIC | 498928
5 |  | finalnotices_pagex4.jpg | GRAPHIC | 382587
| Complete submission text file | 0000059478-25-000109.txt |  | 2441522

Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06351 | Film No.: 25760661
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)